McWilliams et al v. Novartis AG et al
Dennis McWilliams and Lori McWilliams |
Novartis Pharmaceuticals Corporation and Novartis AG |
2:2017cv14302 |
August 23, 2017 |
US District Court for the Southern District of Florida |
Ft Pierce Office |
St. Lucie (Office: Ft Pierce) |
Shaniek M Maynard |
Robin L Rosenberg |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Defendant |
Docket Report
This docket was last retrieved on November 26, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 123 STIPULATION of Dismissal with Prejudice by Dennis McWilliams, Lori McWilliams (Aylstock, Bryan) |
![]() |
Reset Deadlines Per DE#122. Miscellaneous Deadline 11/9/2018. (cqs) |
Filing 121 MOTION for Extension of Time TO FILE DISMISSAL PLEADINGS by Novartis AG, Novartis Pharmaceuticals Corporation. Responses due by 11/5/2018 (Thomas, Michael) |
Filing 120 STIPULATION to Extend Time to File Dismissal Pleadings by Dennis McWilliams, Lori McWilliams (Aylstock, Bryan) |
![]() |
Filing 118 MOTION for Extension of Time TO FILE DISMISSAL re #117 Order Dismissing Case, by Novartis Pharmaceuticals Corporation. Responses due by 9/21/2018 (Attachments: #1 Text of Proposed Order proposed order)(Thomas, Michael) |
![]() |
Filing 116 FINAL MEDIATION REPORT by Dominic Caparello. Disposition: Settled in full.(Gimbel, Albert) |
![]() |
Filing 114 TRANSCRIPT of Motion Hearing held on 07.16.2018 before Judge Robin L. Rosenberg, 1-35 pages, Court Reporter: Pauline Stipes, 561-803-3434 / Pauline_Stipes@flsd.uscourts.gov. Transcript may be viewed at the court public terminal or purchased by contacting the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/23/2018. Redacted Transcript Deadline set for 9/4/2018. Release of Transcript Restriction set for 10/31/2018. (ps) |
Filing 113 TRANSCRIPT of Status Conference held on 06.20.2018 before Judge Robin L. Rosenberg, 1-16 pages, Court Reporter: Pauline Stipes, 561-803-3434 / Pauline_Stipes@flsd.uscourts.gov. Transcript may be viewed at the court public terminal or purchased by contacting the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/23/2018. Redacted Transcript Deadline set for 9/4/2018. Release of Transcript Restriction set for 10/31/2018. (ps) |
Filing 112 NOTICE by Dennis McWilliams, Lori McWilliams Joint Submission of Responses to Objections to Deposition Designations and Objections to Counter Designations (Attachments: #1 Exhibit A, #2 Exhibit B) (Aylstock, Bryan) |
![]() |
Filing 110 NOTICE by Dennis McWilliams, Lori McWilliams Joint Submission of Deposition Designations, Counter-Designations, and Objections to Designations (Attachments: #1 Exhibit A, #2 Exhibit B) (Aylstock, Bryan) |
Filing 109 NOTICE by Dennis McWilliams, Lori McWilliams Joint Notice Regarding Additional Procedures (Aylstock, Bryan) |
Filing 108 PRETRIAL STIPULATION by Dennis McWilliams, Lori McWilliams (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G)(Aylstock, Bryan) |
Filing 107 REPLY to Response to Motion re #100 MOTION for Reconsideration of Order on Summary Judgment filed by Dennis McWilliams, Lori McWilliams. (Aylstock, Bryan) |
Filing 106 NOTICE by Novartis Pharmaceuticals Corporation re 93 Order,,,, Set/Reset Hearings,,, (Thomas, Michael) |
Filing 105 RESPONSE in Opposition re #100 MOTION for Reconsideration of Order on Summary Judgment filed by Novartis Pharmaceuticals Corporation. Replies due by 7/23/2018. (Thomas, Michael) |
![]() |
Filing 103 PAPERLESS Minute Entry for proceedings held before Judge Robin L. Rosenberg: Telephonic Motion Hearing held on 7/16/2018 re #94 MOTION to Permit Contemporaneous Video Transmission Under FRCP 43(a) filed by Dennis McWilliams, Lori McWilliams. Total time in court: 48 minutes. Attorney Appearance(s): Caitlyn Corrine Prichard, Richard M. Elias, Tamara M. Spicer, Robert E. Johnston, Andrew L. Reissaus. Court Reporter: Pauline Stipes, 561-803-3434 / Pauline_Stipes@flsd.uscourts.gov. (ir) |
Filing 102 RESPONSE in Opposition re #94 MOTION to Permit Contemporaneous Video Transmission Under FRCP 43(a) filed by Novartis Pharmaceuticals Corporation. Replies due by 7/20/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Thomas, Michael) |
![]() |
Filing 100 MOTION for Reconsideration of Order on Summary Judgment by Dennis McWilliams, Lori McWilliams. (Aylstock, Bryan) |
Filing 99 NOTICE by Dennis McWilliams, Lori McWilliams Telephonic Appearance of Richard Elias and Tamara Spicer for July 16, 2018 Status Conference (Aylstock, Bryan) |
Filing 98 NOTICE by Novartis Pharmaceuticals Corporation of Telephonic Appearance at July 16, 2018 Status Conference (Thomas, Michael) |
Filing 97 NOTICE by Dennis McWilliams, Lori McWilliams of Service of Demand for Judgment to Defendant (Aylstock, Bryan) |
Filing 96 NOTICE by Dennis McWilliams, Lori McWilliams of Telephonic Appearance for July 16, 2018 Status Conference (Prichard, Caitlyn) |
![]() |
Filing 94 MOTION to Permit Contemporaneous Video Transmission Under FRCP 43(a) by Dennis McWilliams, Lori McWilliams. (Aylstock, Bryan) |
![]() |
![]() |
![]() |
![]() |
![]() |
Filing 88 NOTICE by Novartis Pharmaceuticals Corporation (Thomas, Michael) |
Filing 86 Notice of Supplemental Authority re #75 Response in Support of Motion, by Novartis Pharmaceuticals Corporation (Thomas, Michael) |
![]() |
Filing 85 PAPERLESS Minute Entry for proceedings held before Judge Robin L. Rosenberg: Calendar Call held on 6/20/2018. Total time in court: 20 minutes. Court Reporter: Pauline Stipes, 561-803-3434 / Pauline_Stipes@flsd.uscourts.gov. (mg) |
Filing 84 NOTICE by Dennis McWilliams, Lori McWilliams telephonic appearance (Prichard, Caitlyn) |
Filing 83 NOTICE of Attorney Appearance by Caitlyn Corrine Prichard on behalf of Dennis McWilliams, Lori McWilliams. Attorney Caitlyn Corrine Prichard added to party Dennis McWilliams(pty:pla), Attorney Caitlyn Corrine Prichard added to party Lori McWilliams(pty:pla). (Prichard, Caitlyn) |
Filing 82 Notice of Supplemental Authority re #56 MOTION MOTION TO EXCLUDE TESTIMONY OF DR. SONAL SINGH WITH SUPPORTING MEMORANDUM OF LAW , #60 MOTION TO EXCLUDE TESTIMONY OF DR. ROBERT WAGMEISTER WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation (Thomas, Michael) |
![]() |
Filing 80 NOTICE by Novartis Pharmaceuticals Corporation re #73 Reply to Response to Motion, (Attachments: #1 Exhibit 1) (Thomas, Michael) |
Filing 79 NOTICE of Striking #73 Reply to Response to Motion, filed by Novartis Pharmaceuticals Corporation as to Exhibits Only by Novartis Pharmaceuticals Corporation (Thomas, Michael) |
Filing 78 REPLY in Support re #55 MOTION MOTION TO EXCLUDE TESTIMONY OF CHERYL BLUME, PH.D. WITH SUPPORTING MEMORANDUM OF LAW filed by Novartis Pharmaceuticals Corporation. (Thomas, Michael) Modified title text on 6/12/2018 (asl). |
Filing 77 REPLY in Support re #58 MOTION in Limine AND INCORPORATED MEMORANDUM OF LAW filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Thomas, Michael) Modified title text on 6/12/2018 (asl). |
Filing 76 Statement of: Reply in Support of Its Statement of Material Facts and in Response to Plaintiff's Statement of Additional Material Facts by Novartis Pharmaceuticals Corporation re #64 Statement,,,,,,, #62 Statement,,,,,,,, (Attachments: #1 Exhibit 55)(Thomas, Michael) |
Filing 75 REPLY in Support re #61 MOTION for Summary Judgment WITH SUPPORTING MEMORANDUM OF LAW filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Thomas, Michael) Modified title text on 6/12/2018 (asl). |
Filing 74 REPLY in Support re #56 MOTION MOTION TO EXCLUDE TESTIMONY OF DR. SONAL SINGH WITH SUPPORTING MEMORANDUM OF LAW filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Thomas, Michael) Modified title text on 6/12/2018 (asl). |
Filing 73 REPLY to Response to Motion re #59 MOTION TO EXCLUDE TESTIMONY OF DR. MARK WEISS WITH SUPPORTING MEMORANDUM OF LAW, #57 MOTION MOTION TO EXCLUDE TESTIMONY OF MR. RICHARD HARPER WITH SUPPORTING MEMORANDUM OF LAW , #60 MOTION TO EXCLUDE TESTIMONY OF DR. ROBERT WAGMEISTER WITH SUPPORTING MEMORANDUM OF LAW filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Thomas, Michael) |
Filing 72 REPLY to Response to Motion re #54 MOTION to Strike the Expert Testimony of Javid Moslehi, M.D. and Francis Giles, M.D. filed by Dennis McWilliams, Lori McWilliams. (Aylstock, Bryan) |
Filing 71 RESPONSE in Opposition re #58 MOTION in Limine AND INCORPORATED MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Aylstock, Bryan) |
Filing 70 RESPONSE in Opposition re #54 MOTION to Strike the Expert Testimony of Javid Moslehi, M.D. and Francis Giles, M.D. filed by Novartis Pharmaceuticals Corporation. Replies due by 6/11/2018. (Thomas, Michael) |
Filing 69 RESPONSE in Opposition re #57 MOTION MOTION TO EXCLUDE TESTIMONY OF MR. RICHARD HARPER WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Aylstock, Bryan) |
Filing 68 RESPONSE in Opposition re #55 MOTION MOTION TO EXCLUDE TESTIMONY OF CHERYL BLUME, PH.D. WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Aylstock, Bryan) |
Filing 67 RESPONSE in Opposition re #59 MOTION TO EXCLUDE TESTIMONY OF DR. MARK WEISS WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Aylstock, Bryan) |
Filing 66 RESPONSE in Opposition re #60 MOTION TO EXCLUDE TESTIMONY OF DR. ROBERT WAGMEISTER WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Aylstock, Bryan) |
Filing 65 RESPONSE in Opposition re #56 MOTION MOTION TO EXCLUDE TESTIMONY OF DR. SONAL SINGH WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Aylstock, Bryan) |
Filing 64 Statement of: of Disputed Facts in Opposition to Defendant Novartis Pharmaceutical Corporation's Statement of Material Facts and Statement of Additional Material Facts in Opposition to Movant's Motion for Summary Judgment by Dennis McWilliams, Lori McWilliams re #62 Statement,,,,,,,, (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55, #56 Exhibit 56, #57 Exhibit 57, #58 Exhibit 58, #59 Exhibit 59, #60 Exhibit 60, #61 Exhibit 61, #62 Exhibit 62, #63 Exhibit 63, #64 Exhibit 64, #65 Exhibit 65, #66 Exhibit 66, #67 Exhibit 67, #68 Exhibit 68, #69 Exhibit 69, #70 Exhibit 70, #71 Exhibit 71, #72 Exhibit 72, #73 Exhibit 73, #74 Exhibit 74, #75 Exhibit 75, #76 Exhibit 76, #77 Exhibit 77, #78 Exhibit 78, #79 Exhibit 79, #80 Exhibit 80)(Aylstock, Bryan) |
Filing 63 RESPONSE in Opposition re #61 MOTION for Summary Judgment WITH SUPPORTING MEMORANDUM OF LAW filed by Dennis McWilliams, Lori McWilliams. Replies due by 6/11/2018. (Aylstock, Bryan) |
Filing 62 Statement of: MATERIAL FACTS by Novartis Pharmaceuticals Corporation re #61 MOTION for Summary Judgment WITH SUPPORTING MEMORANDUM OF LAW (Attachments: #1 Exhibit 3-5-18 Walia Dep, #2 Exhibit 3-21-18 Shaikh Dep, #3 Exhibit 4-13-17 Woodman Dep, #4 Exhibit 4-26-18 Blume Dep, #5 Exhibit 7-14-17 Weiss Dep, #6 Exhibit 4-8-17 Habucky Dep, #7 Exhibit 10-29-07 Approval, #8 Exhibit 6-17-10 Approval, #9 Exhibit 4-24-18 Weiss Dep, #10 Exhibit 6-6-2011 Rec, #11 Exhibit 03-08-18 Walia Dep, #12 Exhibit 10-20-14 - Shaikh Rec, #13 Exhibit 10-22-13 Walia Rec, #14 Exhibit 2-6-18 Loyola Dep, #15 Exhibit 9-9-13 Loyola Rec, #16 Exhibit 2018 Label, #17 Exhibit 2-9-18 Maraist Dep, #18 Exhibit 8-27-13 Rec, #19 Exhibit 3-19-22 Maraist Dep, #20 Exhibit 9-10-13 Rec, #21 Exhibit 10-18-17 Rec, #22 Exhibit 11-14-17 Rec, #23 Exhibit 7-12-15 Rec, #24 Exhibit AHA 2017 Update, #25 Exhibit 4-19-18 Wagmeister Dep, #26 Exhibit 6-16-11 Record at 43, #27 Exhibit Lifetime Risks of Cardio Dis, #28 Exhibit 8-25-13 Record at 155, #29 Exhibit Coon et al (2013), #30 Exhibit Levato et al (2013), #31 Exhibit 1-22-18 Blume Report, #32 Exhibit 4-7-17 Habucky Dep, #33 Exhibit 4-25-17 Aghoghovbia Dep, #34 Exhibit 5-2-17 Hong Dep, #35 Exhibit 12-16-10 MSRB Minutes, #36 Exhibit 7-13-11 PAOD label changes, #37 Exhibit 7-31-17 Blume Dep, #38 Exhibit 10-10-11 FDA Memo, #39 Exhibit 10-13-11 FDA lbl feedback, #40 Exhibit 11-18-11 Approval, #41 Exhibit 12-20-12 Approval, #42 Exhibit 3-29-13 PSUR Report, #43 Exhibit 4-5-13 Ltr to FDA, #44 Exhibit 9-27-13 Type C Req, #45 Exhibit 10-25-13 FDA req, #46 Exhibit 11-20-13 FDA Email, #47 Exhibit FDA Comms re Iclusig, #48 Exhibit FDA Iclusig Review, #49 Exhibit Iclusig Memo, #50 Exhibit 12-20-13 FDA Comm, #51 Exhibit 12-30-13 PSS, #52 Exhibit 1-2014 FDA Pub, #53 Exhibit 01-22-14 App Ltr, #54 Exhibit 02-21-14 Email)(Thomas, Michael) |
Filing 61 MOTION for Summary Judgment WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. Responses due by 6/4/2018 (Thomas, Michael) |
Filing 60 MOTION TO EXCLUDE TESTIMONY OF DR. ROBERT WAGMEISTER WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Thomas, Michael) |
Filing 59 MOTION TO EXCLUDE TESTIMONY OF DR. MARK WEISS WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Thomas, Michael) |
Filing 58 MOTION in Limine AND INCORPORATED MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26)(Thomas, Michael) |
Filing 57 MOTION MOTION TO EXCLUDE TESTIMONY OF MR. RICHARD HARPER WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Thomas, Michael) |
Filing 56 MOTION MOTION TO EXCLUDE TESTIMONY OF DR. SONAL SINGH WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9)(Thomas, Michael) |
Filing 55 MOTION MOTION TO EXCLUDE TESTIMONY OF CHERYL BLUME, PH.D. WITH SUPPORTING MEMORANDUM OF LAW by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10)(Thomas, Michael) |
Filing 54 MOTION to Strike the Expert Testimony of Javid Moslehi, M.D. and Francis Giles, M.D. by Dennis McWilliams, Lori McWilliams. Responses due by 6/4/2018 (Attachments: #1 Text of Proposed Order, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13)(Aylstock, Bryan) |
![]() |
![]() |
Filing 51 Joint MOTION for Protective Order and Confidentiality Order by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit, #2 Text of Proposed Order)(Thomas, Michael) |
Filing 50 NOTICE of Attorney Appearance by Michael John Thomas on behalf of Novartis Pharmaceuticals Corporation (Attachments: #1 Certification) (Thomas, Michael) |
![]() |
Filing 48 REPLY to Response to Motion re #43 MOTION to Quash Subpoenas MOTION for Protective Order filed by Dennis McWilliams, Lori McWilliams. (Aylstock, Bryan) |
Filing 47 RESPONSE in Opposition re #43 MOTION to Quash Subpoenas MOTION for Protective Order filed by Novartis Pharmaceuticals Corporation. Replies due by 4/12/2018. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Thomas, Michael) |
![]() |
Filing 45 MOTION to Withdraw as Attorney by Katherine J. Duncan. by Novartis Pharmaceuticals Corporation. Responses due by 4/18/2018 (Thomas, Michael) |
![]() |
Filing 43 MOTION to Quash Subpoenas, MOTION for Protective Order by Dennis McWilliams, Lori McWilliams. (Attachments: #1 Text of Proposed Order, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Aylstock, Bryan) |
Filing 42 MEDIATION REPORT by Dominic M. Caparello. Disposition: Adjourned.(Gimbel, Albert) |
![]() |
Filing 40 ANSWER and Affirmative Defenses to Amended Complaint with Jury Demand by Novartis Pharmaceuticals Corporation. (Thomas, Michael) |
![]() |
![]() |
Filing 37 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Catherine E. Stolar. Filing Fee $ 75.00 Receipt # 113C-10367046 by Novartis Pharmaceuticals Corporation. Responses due by 2/13/2018 (Attachments: #1 Certification)(Thomas, Michael) |
Filing 36 Notice of Entry of Parties Listed NOTE: New Filer(s) will appear twice, since they are also a new party in the case. New Filer(s)/Party(s): Dominic Caparello. (Thomas, Michael) |
Filing 35 Clerks Notice to Filer re #34 Notice of Mediator Selection and/or Hearing. Mediator Not Added; ERROR - The Filer failed to add all mediator. Filer is instructed to file a Notice of Entry of Parties/Mediator and add the additional mediator. (kpe) |
Filing 34 NOTICE of Mediator Hearing. Dominic Caparello selected. Mediation Hearing set for 03/07/18 at 10:00 a.m.. (Thomas, Michael) |
![]() |
Filing 32 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for KATHERINE J. DUNCAN. Filing Fee $ 75.00 Receipt # 113C-10275485 by Novartis AG, Novartis Pharmaceuticals Corporation. Responses due by 1/3/2018 (Attachments: #1 Certification)(Thomas, Michael) |
Filing 31 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for STEPHEN A. KLEIN. Filing Fee $ 75.00 Receipt # 113C-10275437 by Novartis AG, Novartis Pharmaceuticals Corporation. Attorney Michael John Thomas added to party Novartis AG(pty:dft). Responses due by 1/3/2018 (Attachments: #1 Certification)(Thomas, Michael) |
Filing 30 RESPONSE to #15 MOTION TO DISMISS #1 Complaint FOR FAILURE TO STATE A CLAIM and Incorporated Memorandum of Law by Novartis Pharmaceuticals Corporation. (Thomas, Michael) |
Filing 29 Consent to Mediation byNovartis AG, Novartis Pharmaceuticals Corporation(Thomas, Michael) |
Filing 28 RESPONSE in Opposition re #27 MOTION to Dismiss #19 Amended Complaint and Incorporated Memorandum of Law filed by Dennis McWilliams, Lori McWilliams. Replies due by 11/22/2017. (Attachments: #1 Exhibit A)(Aylstock, Bryan) |
Filing 27 MOTION to Dismiss #19 Amended Complaint and Incorporated Memorandum of Law by Novartis Pharmaceuticals Corporation. Responses due by 11/15/2017 (Thomas, Michael) |
![]() |
![]() |
Filing 24 SCHEDULING REPORT - Rule by Dennis McWilliams, Lori McWilliams (Attachments: #1 Exhibit 1, #2 Exhibit Plaintiff Proposed Scheduling Order, #3 Exhibit Defendant Proposed Scheduling Order)(Aylstock, Bryan) |
Filing 23 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Robert E. Johnston. Filing Fee $ 75.00 Receipt # 113C-10119723 by Novartis Pharmaceuticals Corporation. Responses due by 11/1/2017 (Attachments: #1 Certification)(Thomas, Michael) |
Filing 22 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Katharine R. Latimer. Filing Fee $ 75.00 Receipt # 113C-10119700 by Novartis Pharmaceuticals Corporation. Responses due by 11/1/2017 (Attachments: #1 Certification)(Thomas, Michael) |
Filing 21 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Andrew L. Reissaus. Filing Fee $ 75.00 Receipt # 113C-10119328 by Novartis Pharmaceuticals Corporation. Responses due by 11/1/2017 (Attachments: #1 Certification)(Thomas, Michael) |
![]() |
Filing 19 AMENDED COMPLAINT against Novartis AG, Novartis Pharmaceuticals Corporation, filed by Dennis McWilliams, Lori McWilliams.(Aylstock, Bryan) |
![]() |
Filing 17 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Evan C. Murphy. Filing Fee $ 75.00 Receipt # 113C-10086663 by Dennis McWilliams, Lori McWilliams. Responses due by 10/19/2017 (Aylstock, Bryan) |
Filing 16 Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation (Thomas, Michael) |
Filing 15 MOTION TO DISMISS #1 Complaint FOR FAILURE TO STATE A CLAIM and Incorporated Memorandum of Law by Novartis Pharmaceuticals Corporation. Attorney Michael John Thomas added to party Novartis Pharmaceuticals Corporation(pty:dft). Responses due by 10/18/2017 (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Text of Proposed Order Proposed Order)(Thomas, Michael) |
![]() |
Filing 13 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Tamara M. Spicer. Filing Fee $ 75.00 Receipt # 113C-10079298 by Dennis McWilliams, Lori McWilliams. Responses due by 10/17/2017 (Aylstock, Bryan) |
Filing 12 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Richard M. Elias. Filing Fee $ 75.00 Receipt # 113C-10079284 by Dennis McWilliams, Lori McWilliams. Responses due by 10/17/2017 (Aylstock, Bryan) |
Filing 11 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Greg G. Gutzler. Filing Fee $ 75.00 Receipt # 113C-10079264 by Dennis McWilliams, Lori McWilliams. Responses due by 10/17/2017 (Aylstock, Bryan) |
![]() |
Filing 9 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for James G. Onder. Filing Fee $ 75.00 Receipt # 113C-10059493 by Dennis McWilliams, Lori McWilliams. Responses due by 10/10/2017 (Aylstock, Bryan) |
Filing 8 SUMMONS (Affidavit) Returned Executed on #1 Complaint with a 21 day response/answer filing deadline by Dennis McWilliams, Lori McWilliams. Novartis Pharmaceuticals Corporation served on 9/13/2017, answer due 10/4/2017. (Aylstock, Bryan) |
![]() |
Filing 6 Summons Issued as to Novartis AG. (asl) |
Filing 5 NOTICE of Filing Proposed Summons(es) for Novartis AG by Dennis McWilliams, Lori McWilliams (Aylstock, Bryan) |
Filing 4 Clerks Notice to Filer re: Summons(es) cannot be issued. Summons NOT issued for the following reason - Summons for Party Novartis AG, does not have address. (jas) |
Filing 3 Summons Issued as to Novartis Pharmaceuticals Corporation. (jas) |
Filing 2 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Shaniek M. Maynard. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Shaniek M. Maynard is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. Pro se (NON-PRISONER) litigants may receive Notices of Electronic Filings (NEFS) via email after filing a Consent by Pro Se Litigant (NON-PRISONER) to Receive Notices of Electronic Filing. The consent form is available under the forms section of our website. (jas) |
Filing 1 COMPLAINT against All Defendants. Filing fees $ 400.00 receipt number 113C-9995247, filed by Dennis McWilliams, Lori McWilliams. (Attachments: #1 Civil Cover Sheet, #2 Summon(s))(Aylstock, Bryan) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.